Lataa...
Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application
The discovery that a number of aberrant tumorigenic processes and signal transduction pathways are mediated by druggable protein kinases has led to a revolutionary change in nonsmall cell lung cancer (NSCLC) treatment. Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) are...
Tallennettuna:
| Julkaisussa: | Ther Adv Med Oncol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543855/ https://ncbi.nlm.nih.gov/pubmed/26327924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834015595048 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|